Therapeutic Management

Coastal Laboratories delivers precise and actionable results that providers and physicians need to treat patients more effectively.

Coastal Laboratories utilizes infectious disease-trained PharmDs in developing the best therapeutic plan for each patient.

Improving outcomes

Standard of Care                           GroupGroup I                                 Group II

Traditional C&S with Systemic Antibiotics

Molecular Diagnostics with Systemic Antibiotics

Molecular Diagnostics with Customized Topical Antibiotics

% of Patients Healed

48.5%

244/503

62.4%

298/479

90.4%

358/396

In a study  using molecular diagnostics and personalized medicine in wound care, the following outcomes were found:

  • In the “Standard of Care Group,” utilizing traditional culture and sensitivity testing with systemic antibiotics, 48.5% of patients healed. (244/503)

  • In “Group I,” utilizing molecular diagnostics with systemic antibiotics, 62.4% of patients healed. (298/479)

  • In “Group II,” utilizing molecular diagnostics with customized topical antibiotics, 90.4% of patients healed. (358/396)

1

References

  1. Molecular diagnostics and personalized medicine in wound care: assessment of outcomes. S.E.Dowd, R.D.Wolcott, J.Kennedy, C.Jones, and S.B.Cox. Journal of Wound Care 2011 20:5, 232-239